PPH vs. XPH
Compare and contrast key facts about VanEck Vectors Pharmaceutical ETF (PPH) and SPDR S&P Pharmaceuticals ETF (XPH).
PPH and XPH are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. PPH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Pharmaceutical 25 Index. It was launched on Dec 20, 2011. XPH is a passively managed fund by State Street that tracks the performance of the S&P Pharmaceuticals Select Industry Index. It was launched on Jun 19, 2006. Both PPH and XPH are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PPH or XPH.
Performance
PPH vs. XPH - Performance Comparison
Returns By Period
In the year-to-date period, PPH achieves a 9.00% return, which is significantly lower than XPH's 10.70% return. Over the past 10 years, PPH has outperformed XPH with an annualized return of 4.96%, while XPH has yielded a comparatively lower 0.07% annualized return.
PPH
9.00%
-6.61%
-2.86%
14.42%
9.32%
4.96%
XPH
10.70%
-2.44%
11.37%
26.54%
3.80%
0.07%
Key characteristics
| PPH | XPH | |
|---|---|---|
| Sharpe Ratio | 1.34 | 1.52 |
| Sortino Ratio | 1.91 | 2.22 |
| Omega Ratio | 1.24 | 1.26 |
| Calmar Ratio | 1.16 | 0.68 |
| Martin Ratio | 4.29 | 3.93 |
| Ulcer Index | 3.38% | 6.47% |
| Daily Std Dev | 10.80% | 16.77% |
| Max Drawdown | -46.49% | -48.03% |
| Current Drawdown | -11.68% | -20.89% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
PPH vs. XPH - Expense Ratio Comparison
PPH has a 0.36% expense ratio, which is higher than XPH's 0.35% expense ratio.
Correlation
The correlation between PPH and XPH is 0.78, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Risk-Adjusted Performance
PPH vs. XPH - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Pharmaceutical ETF (PPH) and SPDR S&P Pharmaceuticals ETF (XPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PPH vs. XPH - Dividend Comparison
PPH's dividend yield for the trailing twelve months is around 1.84%, more than XPH's 1.53% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PPH VanEck Vectors Pharmaceutical ETF | 1.84% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% | 1.71% | 2.03% |
XPH SPDR S&P Pharmaceuticals ETF | 1.53% | 1.28% | 1.64% | 0.95% | 0.47% | 0.64% | 0.65% | 0.67% | 0.63% | 7.15% | 5.55% | 2.06% |
Drawdowns
PPH vs. XPH - Drawdown Comparison
The maximum PPH drawdown since its inception was -46.49%, roughly equal to the maximum XPH drawdown of -48.03%. Use the drawdown chart below to compare losses from any high point for PPH and XPH. For additional features, visit the drawdowns tool.
Volatility
PPH vs. XPH - Volatility Comparison
The current volatility for VanEck Vectors Pharmaceutical ETF (PPH) is 3.94%, while SPDR S&P Pharmaceuticals ETF (XPH) has a volatility of 5.29%. This indicates that PPH experiences smaller price fluctuations and is considered to be less risky than XPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.